Paweł Chrom

Effects of an outpatient intervention comprising nurse‐led non‐invasive assessments, telemedicine support and remote cardiologists' decisions in patients with heart failure ( <scp>AMULET</scp> study): a randomised controlled trial

Paweł Krzesiński, Ewa A. Jankowska, Janusz Siebert et al. · European Journal of Heart Failure · 2021 · 54 citations · Full text

Medicine, Cardiology, Internal Medicine +16

Fuhrman Grade and Neutrophil-To-Lymphocyte Ratio Influence on Survival in Patients With Metastatic Renal Cell Carcinoma Treated With First-Line Tyrosine Kinase Inhibitors

Paweł Chrom, Aleksandra Semeniuk-Wojtaś, Lubomir Bodnar et al. · Clinical Genitourinary Cancer · 2016 · 42 citations · Full text

Medicine, Oncology, Pharmacology +17

Incorporating Neutrophil-to-lymphocyte Ratio and Platelet-to-lymphocyte Ratio in Place of Neutrophil Count and Platelet Count Improves Prognostic Accuracy of the International Metastatic Renal Cell Carcinoma Database Consortium Model

Paweł Chrom, Lubomir Bodnar, Cezary Szczylik · Cancer Research and Treatment · 2017 · 37 citations · Full text

Medicine, Oncology, Pharmacology +16

External validation of the systemic immune-inflammation index as a prognostic factor in metastatic renal cell carcinoma and its implementation within the international metastatic renal cell carcinoma database consortium model

Paweł Chrom, Jakub Żołnierek, Lubomir Bodnar et al. · International Journal of Clinical Oncology · 2019 · 32 citations

Medicine, Immunology, Oncology +17

Real-world Experience of Cabozantinib as Second- or Subsequent Line Treatment in Patients With Metastatic Renal Cell Carcinoma: Data From the Polish Managed Access Program

Lubomir Bodnar, Anna Kopczyńska, Jakub Żołnierek et al. · Clinical Genitourinary Cancer · 2019 · 29 citations

Medicine, Oncology, Pharmacology +12